Procedia of Social Sciences and Humanities
Vol. 2 (2022): Proceedings of the 1st International Conference on Community Education, Economics, Psychology And Social Studies (ICCEEPS 2021)
Articles

Frequency Of Cyp3a5 (A6986g) Gene Polymorphism In Patients With BA, COPD, And ACO

View article
  • Raufov A.A.,,
  • FayzullaevaN.Ya.,
  • Ruzibakieva M.R.
Raufov A.A.,
Bukhara State Medical Institute, Bukhara, Republic of Uzbekistan
FayzullaevaN.Ya.
Bukhara State Medical Institute, Bukhara, Republic of Uzbekistan
Ruzibakieva M.R.
Bukhara State Medical Institute, Bukhara, Republic of Uzbekistan
DOI: https://doi.org/10.21070/pssh.v2i.109
Published April 30, 2022
How to Cite
Raufov A.A., FayzullaevaN.Ya., & Ruzibakieva M.R. (2022). Frequency Of Cyp3a5 (A6986g) Gene Polymorphism In Patients With BA, COPD, And ACO. Procedia of Social Sciences and Humanities, 2, 44-46. https://doi.org/10.21070/pssh.v2i.109

Copyright (c) 2022 Raufov A.A.,, FayzullaevaN.Ya., Ruzibakieva M.R.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Asthma and COPD are the most common chronic respiratory diseases, each with a specific pathophysiology. Usually, asthma is characterized by chronic inflammation of the airways with reversible symptoms, while COPD is characterized by persistent respiratory changes in the bronchopulmonary system. However, patients can sometimes have clinical features of both diseases, and this condition is called the asthma-COPD overlap (ACO) recommended by the joint guidelines of GINA (Global Strategy for the Management and Prevention of Asthma) and GOLD (Global Initiative on Chronic Obstructive Pulmonary Disease). According to this guide, ACOis characterized by "permanent airflow limitation with some features of asthma and COPD."

View article

References

1. Saidova M., Kamilova U. Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis //American Journal of Medicine and Medical Sciences. –
2019. – Т. 9. – №. 8. – С. 281.
2. Саидова М. М., Камилова У. К. Сердечно-сосудистый риск по шкале MSCORE у больных ревматоидным артритом //Евразийский
кардиологический журнал. – 2019. – №. S1. – С. 381.
3. Саидова М. М., Камилова У. К. Анализ встречаемости кардиоваскулярной коморбидности у больных ревматоидным артритом //Артериальная
гипертония 2017 как междисциплинарная проблема. – 2017. – С. 41-42.ф
4. Meliboyeva S. S. Q. et al. Comparative efficiency of the preparation" Nodinorm" in complex treatment of fibrocystic mastopathy //ACADEMICIA: An International Multidisciplinary Research Journal. – 2021. – Т. 11. – №. 10. –
С. 1591-1596